Data / Form D filings / Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc.: Form D filing
Brenig Therapeutics, Inc., a biotechnology company in Dover, DE, filed a Form D with the SEC in 2024. The latest, on July 30, 2024, reports $30 million sold of a $65 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 THE GREEN, SUITE 8235, Dover, DE, 19901
- Phone
- (818) 326-9933
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2030788
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | New notice | $65,000,000 | $30,000,000 | $35,000,000 | 6 | Jul 16, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Keno Gutierrez | Director | |
| Iain Dukes | Executive Officer, Director | |
| Edward Mathers | Director | |
| Nikolay Savchuk | Executive Officer, Director | |
| Michele Cucullu | Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Jul 29, 2024 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Brenig Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.